+ All Categories
Home > Documents > Mark Lynch Clinical Lead Urology CUH [email protected] [email protected]...

Mark Lynch Clinical Lead Urology CUH [email protected] [email protected]...

Date post: 22-Dec-2015
Category:
Upload: irma-cobb
View: 216 times
Download: 1 times
Share this document with a friend
Popular Tags:
16
Mark Lynch Clinical Lead Urology CUH [email protected] [email protected] [email protected]
Transcript
Page 1: Mark Lynch Clinical Lead Urology CUH Mlynch100@doctors.org.uk Mark.lynch@croydonhealth.nhs.uk Mark.lynch@stgeorges.nhs.uk.

Mark Lynch

Clinical Lead Urology CUH

[email protected]@[email protected]

Page 2: Mark Lynch Clinical Lead Urology CUH Mlynch100@doctors.org.uk Mark.lynch@croydonhealth.nhs.uk Mark.lynch@stgeorges.nhs.uk.

UTI• ADHERERNCE MECHANISMS

• FIMBRIAE

• type I – mannose sensitive, adhere to uroplakins Ia and Ib on urothelium

• P type – mannose insensitive

• Pap (P pili associated with pyelonephritis) – 4 proteins (F, A, G, E)

• PapG is receptor component• 3 subtypes (I, II, III)• PapG subtype II associated more with

pyelonephritis• PapG subtype III associated more with cystitis

Page 3: Mark Lynch Clinical Lead Urology CUH Mlynch100@doctors.org.uk Mark.lynch@croydonhealth.nhs.uk Mark.lynch@stgeorges.nhs.uk.

UTIs

• UTI• Infection• Complicated or not• Recurrent• Management

• Infection and stones – hand in hand

Page 4: Mark Lynch Clinical Lead Urology CUH Mlynch100@doctors.org.uk Mark.lynch@croydonhealth.nhs.uk Mark.lynch@stgeorges.nhs.uk.

UTIs or cystitis

• 30% of women have at least one UTI in their lifetime

• Rare in Men – investigate• Recurrent UTIs in women warrant

investigation• $1.6Bn / year in US

Forman B, Am J Med 2002

Page 5: Mark Lynch Clinical Lead Urology CUH Mlynch100@doctors.org.uk Mark.lynch@croydonhealth.nhs.uk Mark.lynch@stgeorges.nhs.uk.

UTIs – risk factors

• Host immunity vs. Bacterial virulence• Host– Bacterial flora– Immunity and comorbidity– Stasis– Foreign body

• Bacterial virulence– Fimbriae and Pili– Antimicrobial resistance

Page 6: Mark Lynch Clinical Lead Urology CUH Mlynch100@doctors.org.uk Mark.lynch@croydonhealth.nhs.uk Mark.lynch@stgeorges.nhs.uk.

UTI – excluding a cause

• Complicated:– Structural or functional

abnormality or underlying disease to increase infection…• DM, renal insufficiency• Urological (DxT, childhood Hx),

neurological• Pregnancy, voiding dysfunction

– All men

Page 7: Mark Lynch Clinical Lead Urology CUH Mlynch100@doctors.org.uk Mark.lynch@croydonhealth.nhs.uk Mark.lynch@stgeorges.nhs.uk.

UTIs – bacterial resistance

• E.Coli and coliforms – 80%• Staph. Sap. – 10%• Klebsiella, Enterobacter, Proteus ..– Note foreign travel– Recent in hospital care

Ronald, A Am J Med 2002

Page 8: Mark Lynch Clinical Lead Urology CUH Mlynch100@doctors.org.uk Mark.lynch@croydonhealth.nhs.uk Mark.lynch@stgeorges.nhs.uk.
Page 9: Mark Lynch Clinical Lead Urology CUH Mlynch100@doctors.org.uk Mark.lynch@croydonhealth.nhs.uk Mark.lynch@stgeorges.nhs.uk.

Recurrent UTI - referral

• UTIs that fail to respond to appropriate antibiotics.

• >2 UTI in 6 months• >3 in one year• In reality – balance of risk and impact

Page 10: Mark Lynch Clinical Lead Urology CUH Mlynch100@doctors.org.uk Mark.lynch@croydonhealth.nhs.uk Mark.lynch@stgeorges.nhs.uk.

Recurrent UTI - management

• History (Current, childhood, family, risk factors…smoking)

• Examination – including pelvic examination

• MSU, bladder diary, GFR, USS, Flexi / Cystoscopy +EUA

• Pathology: Anatomical, functional, TCC, Stones

Page 11: Mark Lynch Clinical Lead Urology CUH Mlynch100@doctors.org.uk Mark.lynch@croydonhealth.nhs.uk Mark.lynch@stgeorges.nhs.uk.

Recurrent UTI - management

Page 12: Mark Lynch Clinical Lead Urology CUH Mlynch100@doctors.org.uk Mark.lynch@croydonhealth.nhs.uk Mark.lynch@stgeorges.nhs.uk.

UTIs• Very common• Confirm the infection and sensitivities• Refer complicated and/or recurrent UTIs• Beware red flags• Multi modality approach to treatment

• Questions…• UTIs…• Pathways…• Anything else Urological…

Page 13: Mark Lynch Clinical Lead Urology CUH Mlynch100@doctors.org.uk Mark.lynch@croydonhealth.nhs.uk Mark.lynch@stgeorges.nhs.uk.
Page 14: Mark Lynch Clinical Lead Urology CUH Mlynch100@doctors.org.uk Mark.lynch@croydonhealth.nhs.uk Mark.lynch@stgeorges.nhs.uk.

Renal Colic and Stones

• 10% risk, 50% recurrence risk at 10 years

• Risk factors include:– Geography– Diet– Anatomical– M>F– Fluid intake– Genetics (Cysteinuria)

Page 15: Mark Lynch Clinical Lead Urology CUH Mlynch100@doctors.org.uk Mark.lynch@croydonhealth.nhs.uk Mark.lynch@stgeorges.nhs.uk.

Renal Colic and Stones at CUH

• Pain relief• History• Examination• Gold standard ED

management– CT KUB– Early diagnosis– Early treatment– Stone clinic F/U– Access to tertiary care

Page 16: Mark Lynch Clinical Lead Urology CUH Mlynch100@doctors.org.uk Mark.lynch@croydonhealth.nhs.uk Mark.lynch@stgeorges.nhs.uk.

Renal Colic and stones at CUH

• CUH – Laser lithotripsy– ESWL– Dedicated stone clinic– Seamless link with SGH

• SGH– PCNL– URS (day case)


Recommended